化工社化工社 化学情報印刷レポート · 研究参考用
Pyrazole → 3-(1-{[2-(1H-pyrazol-1-yl)-3',5'-bis(trifluoromethyl)biphenyl-4-yl]carbonyl}pyrrolidin-3-yl)pyridine
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Pyrazole | HCID 1048 | — |
| 反応物 | Salicylaldehyde oxime | HCID 7200 | — |
| 反応物 | Cesium carbonate | HCID 10796 | — |
| 反応物 | 3-(1-{[2-Bromo-3',5'-bis(trifluoromethyl)biphenyl-4-yl]carbonyl}pyrrolidin-3-yl)pyridine | HCID 86657753 | — |
| 触媒 | HCID 178419072 | HCID 178419072 | — |
| 溶媒 | Acetonitrile | HCID 6342 | — |
| 生成物 | 3-(1-{[2-(1H-pyrazol-1-yl)-3',5'-bis(trifluoromethyl)biphenyl-4-yl]carbonyl}pyrrolidin-3-yl)pyridine | HCID 46847591 | — |
反応手順
A solution of 3b (54.0 mg, 0.099 mmol), pyrazole (50.7 mg, 0.745 mmol), salicylaldoxime (19.8 mg, 0.145 mmol), copper(I) oxide (16.6 mg, 0.116 mmol) and cesium carbonate (265 mg, 0.812 mmol) in acetonitrile (1.00 mL) was heated to 120° C. in a sealed microwave vial for a total of 60 min. The reaction mixture was cooled to rt, concentrated in vacuo, and the resulting crude residue was purified by preparative reversed phase HPLC on YMC Pack Pro C18 stationary phase (CH3CN/H2O as eluent, 0.05% TFA as modifier), followed by lyophilization of the purified fractions to afford the title compound 10a. m/z (ES) 531 (MH)+.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US08367679B2 |
| 出典データセット | uspto-grants-2013_02 |
| ORD ID | ord-a453bc123ad646129051bb5ef7295e14 |
| 出典メモ | uspto-grants-2013_02 |